Neoadjuvant low-dose radiotherapy plus durvalumab and chemotherapy for potentially resectable stage III NSCLC: A phase Ib dose-escalation study

Autor:	Li, Juan, Lu, Shun, Tian, Yuke, Jiang, Lan, Li, Lu, Xie, Shao-Hua, Li, Qiang
Zdroj:	In Radiotherapy and Oncology July 2024 196
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect